Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Enhanced metastatic dissemination to multiple organs by melanoma and lymphoma cells in timp-3−/− mice

Oncogene volume 25, pages 6489–6496 (2006)Cite this article

Abstract

Identifying versatile inhibitors of metastasis that operate in multiple sites against distinct cancer cell types is important for designing novel therapeutics for metastasis. We show that multiple tissues of timp-3−/− mice are more susceptible to metastatic colonization. Overall, a 5–14-fold increase in liver and kidney colonization occurred by EL-4 lymphoma cells, and a twofold increase upon targeting B16F10 melanoma cells to the bone or lung of timp-3−/− mice. There was a general lack of macrophage or neutrophil localization to metastases in the liver, kidney and lung, and of osteoclasts to bone in both genotypes. Analysis of lung showed that proliferation or angiogenesis were unaltered within the metastatic colonies. Lung-trap assays revealed that initial tumor cell trapping was similar in the lung vasculature of timp-3−/− and wild-type mice. However, more tumor cells were found in timp-3−/− lungs at 48 and 96 h after tumor cell injection indicating more efficient extravasation and initial proliferation. Activation of pro-MMP-2 was greater in timp-3−/− lungs at these time points. These data demonstrate TIMP-3 functions to inhibit metastatic dissemination of diverse cancer cells to multiple organs. TIMP-3 regulates MMP-2 activation to limit tumor cell extravasation and subsequent colonization of the lung, without augmenting inflammatory cell response.

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Ahonen M, Baker AH, Kahari VM . (1998). Cancer Res 58: 2310–2315.

  • Airola K, Karonen T, Vaalamo M, Lehti K, Lohi J, Kariniemi AL et al. (1999). Br J Cancer 80: 733–743.

  • Banerji A, Chakrabarti J, Mitra A, Chatterjee A . (2004). Cancer Lett 211: 235–242.

  • Cameron MD, Schmidt EE, Kerkvliet N, Nadkarni KV, Morris VL, Groom AC et al. (2000). Cancer Res 60: 2541–2546.

  • Castells A, Rustgi AK . (2003). Tumour growth, invasion and metastasis. In Rustgi AK (ed). Gastrointestinal Cancers: A Companion To Sleisenger & Fordtran's GI And Liver Disease. WB Saunders: New York, pp 69–79.

    Google Scholar 

  • Chang C, Werb Z . (2001). Trends Cell Biol 11: S37–S43.

  • Coussens LM, Werb Z . (2002). Nature 420: 860–867.

  • Cruz-Munoz W, Kim I, Khokha R . (2006). Oncogene 25: 650–655.

  • De Larco JE, Wuertz BR, Gurcht LT . (2004). Clin Cancer Res 10: 4895–4900.

  • Ding L, Sunamura M, Kodama T, Yamauchi J, Duda DG, Shimamura H et al. (2001). Br J Cancer 85: 431–438.

  • English JL, Kassiri Z, Koskivirta I, Atkinson SJ, Di Grappa M, Soloway PD et al. (2006). J Biol Chem 281: 10337–10346.

  • Gill SE, Pape MC, Khokha R, Watson AJ, Leco KJ . (2003). Dev Biol 261: 313–323.

  • Hofmann UB, Eggert AA, Blass K, Brocker EB, Becker JC . (2005). Arch Dermatol Res 297: 154–160.

  • Hofmann UB, Westphal JR, Zendman AJ, Becker JC, Ruiter DJ, van Muijen GN . (2000). J Pathol 191: 245–256.

  • Itoh T, Tanioka M, Yoshida H, Yoshioka T, Nishimoto H, Itohara S . (1998). Cancer Res 58: 1048–1051.

  • Kassiri Z, Oudit GY, Sanchez O, Dawood F, Mohammed FF, Nuttall RK et al. (2005). Circ Res 97: 380–390.

  • Khatib AM, Kontogiannea M, Fallavollita L, Jamison B, Meterissian S, Brodt P . (1999). Cancer Res 59: 1356–1361.

  • Kitakata H, Nemoto-Sasaki Y, Takahashi Y, Kondo T, Mai M, Mukaida N . (2002). Cancer Res 62: 6682–6687.

  • Leco KJ, Khokha R, Pavloff N, Hawkes SP, Edwards DR . (1994). J Biol Chem 269: 9352–9360.

  • Leco KJ, Waterhouse P, Sanchez OH, Gowing KL, Poole AR, Wakeham A et al. (2001). J Clin Invest 108: 817–829.

  • Lin EY, Nguyen AV, Russell RG, Pollard JW . (2001). J Exp Med 193: 727–740.

  • Lum L, Wong BR, Josien R, Becherer JD, Erdjument-Bromage H, Schlondorff J et al. (1999). J Biol Chem 274: 13613–13618.

  • Miyazaki T, Kato H, Nakajima M, Faried A, Takita J, Sohda M et al. (2004). Br J Cancer 91: 1556–1560.

  • Mohammed FF, Smookler DS, Taylor SE, Fingleton B, Kassiri Z, Sanchez OH et al. (2004). Nat Genet 36: 969–977.

  • Mundy GR . (2002). Nat Rev Cancer 2: 584–593.

  • Nuttall RK, Sampieri CL, Pennington CJ, Gill SE, Schultz GA, Edwards DR . (2004). FEBS Lett 563: 129–134.

  • Orr FW, Kostenuik P, Sanchez-Sweatman OH, Singh G . (1993). Breast Cancer Res Treat 25: 151–163.

  • Pastorino U, Andreola S, Tagliabue E, Pezzella F, Incarbone M, Sozzi G et al. (1997). J Clin Oncol 15: 2858–2865.

  • Perez M, Migliaccio S, Taranta A, Festuccia C, Orru L, Brama M et al. (2001). Eur J Cancer 37: 629–640.

  • Powe DG, Brough JL, Carter GI, Bailey EM, Stetler-Stevenson WG, Turner DR et al. (1997). Br J Cancer 75: 1678–1683.

  • Salmela MT, Karjalainen-Lindsberg ML, Jeskanen L, Saarialho-Kere U . (2003). Mod Pathol 16: 108–114.

  • Sanchez-Sweatman OH, Lee J, Orr FW, Singh G . (1997). Eur J Cancer 33: 918–925.

  • Shamamian P, Schwartz JD, Pocock BJ, Monea S, Whiting D, Marcus SG et al. (2001). J Cell Physiol 189: 197–206.

  • Soloway PD, Alexander CM, Werb Z, Jaenisch R . (1996). Oncogene 13: 2307–2314.

  • Spurbeck WW, Ng CY, Strom TS, Vanin EF, Davidoff AM . (2002). Blood 100: 3361–3368.

  • Urban BA, Fishman EK . (2000). Radiographics 20: 197–212.

  • Woessner Jr JF . (2001). J Clin Invest 108: 799–800.

  • Yu WH, Yu S, Meng Q, Brew K, Woessner Jr JF . (2000). J Biol Chem 275: 31226–31232.

  • Zhang L, Hill RP . (2004). Cancer Res 64: 4180–4189.

Download references

Acknowledgements

We thank Robert Kuba, David Smookler and Dr Hui Fang for their technical assistance. This research is supported by grants from CIHR to RK.

Author information

Authors and Affiliations

  1. Ontario Cancer Research, University of Toronto, Toronto, Ontario, Canada

    W Cruz-Munoz, M Di Grappa, J L English, R P Hill & R Khokha

  2. University of Ontario Institute of Technology, Oshawa, Ontario, Canada

    O H Sanchez

Authors
  1. W Cruz-Munoz
    View author publications

    Search author on:PubMed Google Scholar

  2. O H Sanchez
    View author publications

    Search author on:PubMed Google Scholar

  3. M Di Grappa
    View author publications

    Search author on:PubMed Google Scholar

  4. J L English
    View author publications

    Search author on:PubMed Google Scholar

  5. R P Hill
    View author publications

    Search author on:PubMed Google Scholar

  6. R Khokha
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to R Khokha.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cruz-Munoz, W., Sanchez, O., Di Grappa, M. et al. Enhanced metastatic dissemination to multiple organs by melanoma and lymphoma cells in timp-3−/− mice. Oncogene 25, 6489–6496 (2006). https://doi.org/10.1038/sj.onc.1209663

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/sj.onc.1209663

Keywords

This article is cited by

Search

Advanced search

Quick links